cancer clinical trials in troy, NY
|
Samaritan Hospital at Northeast Health
Troy, New York 12180 Breast Cancer
|
|
Samaritan Hospital at Northeast Health
Troy, New York 12180 Breast Cancer
|
|
Samaritan Hospital at Northeast Health
Troy, New York 12180 Colorectal Cancer
|
|
New York Oncology Hematology, P.C. NYOH Latham
Troy, New York 12180 Breast Cancer
|
|
New York Oncology Hematology PC - Troy
Troy, New York 12180 Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
|
|
New York Oncology Hematology PC - Troy
Troy, New York 12180 Clear Cell Renal Cell Carcinoma, Papillary Renal Cell Carcinoma, Stage I Renal Cell Cancer, Stage II Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
|
|
Samaritan Hospital at Northeast Health
Troy, New York 12180 Breast Cancer
|
|
New York Oncology Hematology PC - Troy
Troy, New York 12180 Male Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer
|
|
Samaritan Hospital at Northeast Health
Troy, New York 12180 Neurotoxicity Syndromes, Pain, Peripheral Neuropathy, Unspecified Adult Solid Tumor, Protocol Specific
|
|
Troy Cancer Treatment Program
Troy, New York 12180 Breast Cancer
|
|
New York Oncology Hematology, P.C. NYOH Amsterdam
Trial Locations New York Oncology Hematology, P.C. NYOH Amsterdam New York Oncology Hematology, P.C. NYOH@AlbanyMedicalCenter(2) Gastrointestinal Stromal Tumor (GIST)
|
|
Troy Cancer Treatment Program
Troy, New York 12180 Breast Cancer
|
|
New York Oncology Hematology, P.C. Dept. of New York Oncology. PC
Troy, New York 12180 Myelodysplastic Syndromes
|
|
Location#19
Troy, New York 12180 Metastatic Breast Cancer
|
|
US Oncology - Troy Cancer Treatment Program
Troy, New York 12180 Multiple Myeloma
|
|
New York Oncology Hematology, P.C. Dept. of New York Oncology. PC
Troy, New York 12180 Metastatic Renal Cell Carcinoma
|
|
New York Oncology Hematology PC - Troy
Troy, New York 12180 Gastrinoma, Glucagonoma, Insulinoma, Pancreatic Alpha Cell Adenoma, Pancreatic Alpha Cell Carcinoma, Pancreatic Beta Islet Cell Adenoma, Pancreatic Beta Islet Cell Carcinoma, Pancreatic Delta Cell Adenoma, Pancreatic Delta Cell Carcinoma, Pancreatic G-cell Adenoma, Pancreatic G-cell Carcinoma, Pancreatic Polypeptide Tumor, Recurrent Islet Cell Carcinoma, Recurrent Pancreatic Cancer, Somatostatinoma, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer
|
|
New York Oncology Hematology PC - Troy
Troy, New York 12180 Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
|
|
New York Oncology Hematology PC - Troy
Troy, New York 12180 Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
|
|
New York Oncology Hematology, P.C. Dept. of New York Oncology. PC
Troy, New York 12180 Metastatic Breast Cancer
|
|
New York Oncology Hematology, P.C. Dept. of New York Oncology. PC
Troy, New York 12180 Breast Cancer
|
|
New York Oncology Hematology, P.C. SC
Trial Locations New York Oncology Hematology, P.C. SC New York Oncology Hematology, P.C. SC - 2 GIST and CML
|
